Dr. Vassiliki Papadimitrakopoulou
Claim this profileStudies Lung Cancer
1 reported clinical trial
2 drugs studied
More about Vassiliki Papadimitrakopoulou
Clinical Trial Related9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Vassiliki Papadimitrakopoulou has experience with
- Ipilimumab
- Nivolumab
Breakdown of trials Vassiliki Papadimitrakopoulou has run
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vassiliki Papadimitrakopoulou specialize in?
Vassiliki Papadimitrakopoulou focuses on Lung Cancer and other conditions. In particular, much of their work with Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Vassiliki Papadimitrakopoulou currently recruiting for clinical trials?
No, Vassiliki Papadimitrakopoulou is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Vassiliki Papadimitrakopoulou has studied deeply?
Yes, Vassiliki Papadimitrakopoulou has studied treatments such as Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Vassiliki Papadimitrakopoulou?
Apply for one of the trials that Vassiliki Papadimitrakopoulou is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.